Pfizer posted better than expected profits and revenues for the second quarter and raised its outlook for the year on the strong performance, including sales of its COVID-19 vaccine.

The company now anticipates revenue from that vaccine this year to reach $33.5 billion for 2.1 billion doses.

Pfizer Inc. reported second-quarter net income of $5.56 billion Wednesday, or 98 cents per share, or $1.07 per share when one-time gains and losses are removed. That far exceeds the per-share earnings of 97 cents that Wall Street had expected, according to a survey by Zacks Investment Research.

The drugmaker posted revenue of $18.98 billion, also better than expected.

Pfizer expects full-year earnings in the range of $3.95 to $4.05 per share, with revenue in the range of $78 billion to $80 billion.

_____

A portion of this story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PFE at https://www.zacks.com/ap/PFE